Delivery Order SPE2DB22D2007-SPE2DB24FH6MQ

Award Date 10/24/23
Potential Completion Date 10/25/23
Potential Value $25K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,127.09 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,861.12 firm fixed-price delivery order covers the supply of NURTEC ODT 75 mg tablets to the DLA. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, valued at $7,539.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB24FT1JF) from the Defense Logistics Agency (DLA) valued at $11,427.67. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period ending on January 16, 2024. The contract is a Firm Fixed Price, and there is no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $16,913.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The contract covers the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military and veteran healthcare programs. This award was made...
This federal contract award, with a value of $56,094.82, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the DLA. This appears to be a firm-fixed price delivery order contract, with a completion date of February 6, 2024. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract, valued at $4,902.66, is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support federal government healthcare needs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $5,135.28, is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range...
This federal contract award, valued at $76,757.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with an ultimate completion date of September 2, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $10,678.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order contract is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract is a firm fixed-price delivery order with an ultimate completion date of December 3, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FH6MQ
    Delivery Order

This federal contract award, valued at $25,171.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This is an open competition contract with no set-aside designation.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:23 AM